Literature DB >> 387311

Antibodies to motor endplates demonstrated with the immunofluorescence technique.

I R Sondag-Tschroots, R C Schulz-Raateland, H K van Walbeek, T E Feltkamp.   

Abstract

Antibodies to acetylcholine receptors (AChR) are probably directly responsible for the pathogenesis of myasthenia gravis (MG). Methods for the demonstration of these antibodies are complicated. The present study shows that the antibodies can also be revealed by the use of the simple indirect immunofluorescence technique with rat diaphragm as substrate. Antibodies were demonstrated with FITC-labelled anti-human Ig. The location on the motor endplates was confirmed by using a TRITC-labelled anti-alpha-bungarotoxin system. Antibodies to motor endplates were only demonstrated in MG and not in either twenty-two patients with neuromuscular disorders or fifty normal subjects. Antibodies to motor endplates were found in only twelve out of fifty-seven MG patients. In fifteen of the other forty-five patients, antibodies were found of the classical anti-skeletal muscle type, 'overluminating' the anti-motor endplate antibodies.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 387311      PMCID: PMC1537818     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Acetylcholine receptor antibodies in myasthenia gravis.

Authors:  S H Appel; R R Almon; N Levy
Journal:  N Engl J Med       Date:  1975-10-09       Impact factor: 91.245

2.  A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES.

Authors:  M J KARNOVSKY; L ROOTS
Journal:  J Histochem Cytochem       Date:  1964-03       Impact factor: 2.479

3.  A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis.

Authors:  V M Monnier; B W Fulpius
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

4.  The skeletal muscle binding site of antistriated muscle antibody in myasthenia gravis: an electron microscopic immunohistochemical study using peroxidase conjugated antibody fragments.

Authors:  J R Mendell; J N Whitaker; W K Engel
Journal:  J Immunol       Date:  1973-09       Impact factor: 5.422

5.  Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.

Authors:  R R Almon; C G Andrew; S H Appel
Journal:  Science       Date:  1974-10-04       Impact factor: 47.728

6.  Autoimmune response to acetylcholine receptor.

Authors:  J Patrick; J Lindstrom
Journal:  Science       Date:  1973-05-25       Impact factor: 47.728

7.  Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction.

Authors:  A N Bender; S P Ringel; W K Engel; M P Daniels; Z Vogel
Journal:  Lancet       Date:  1975-03-15       Impact factor: 79.321

8.  Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis.

Authors:  A Aharonov; O Abramsky; R Tarrab-Hazdai; S Fuchs
Journal:  Lancet       Date:  1975-08-23       Impact factor: 79.321

9.  Antibodies to salivary duct cells, and other autoantibodies, in patients with Sjögren's syndrome and other idiopathic autoimmune diseases.

Authors:  T E Feltkamp; A L van Rossum
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

10.  An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis.

Authors:  J Lindstrom
Journal:  Clin Immunol Immunopathol       Date:  1977-01
  10 in total
  1 in total

1.  Anti-acetylcholine receptor antibodies.

Authors:  A Vincent; J Newsom Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.